| Year |
Citation |
Score |
| 2022 |
Aquino-Acevedo AN, Knochenhauer H, Castillo-Ocampo Y, Ortiz-León M, Rivera-López YA, Morales-López C, Cruz-Robles ME, Hernández-Cordero ER, Russell S, Whitaker R, Bonilla-Claudio M, Chen DT, Dutil J, Gaillard SL, Yi JS, ... ... Armaiz-Pena GN, et al. Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer. Brain, Behavior, & Immunity - Health. 26: 100558. PMID 36439058 DOI: 10.1016/j.bbih.2022.100558 |
0.377 |
|
| 2021 |
Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, et al. Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature Medicine. PMID 34799731 DOI: 10.1038/s41591-021-01566-5 |
0.48 |
|
| 2021 |
Jusino S, Rivera-Rivera Y, Chardón-Colón C, Ruiz-Justiz AJ, Vélez-Velázquez J, Isidro A, Cruz-Robles ME, Bonilla-Claudio M, Armaiz-Pena GN, Saavedra HI. E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer. Experimental Biology and Medicine (Maywood, N.J.). 15353702211035693. PMID 34365840 DOI: 10.1177/15353702211035693 |
0.366 |
|
| 2021 |
Mangala LS, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MMK, Lin YG, Nick AM, Danes CG, Lee JW, Jennings NB, Vivas-Mejia PE, et al. Editor's Note: Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 27: 4454. PMID 34341059 DOI: 10.1158/1078-0432.CCR-21-2120 |
0.375 |
|
| 2021 |
Kim HS, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MMK, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, et al. Editor's Note: Functional Roles of and in Ovarian Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 27: 4452. PMID 34341057 DOI: 10.1158/1078-0432.CCR-21-2118 |
0.349 |
|
| 2021 |
Matsuo K, Nishimura M, Bottsford-Miller JN, Huang J, Komurov K, Armaiz-Pena GN, Shahzad MMK, Stone RL, Roh JW, Sanguino AM, Lu C, Im DD, Rosenshien NB, Sakakibara A, Nagano T, et al. Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 27: 4450. PMID 34341055 DOI: 10.1158/1078-0432.CCR-21-2116 |
0.369 |
|
| 2021 |
Dash S, Yoder S, Mesa T, Smith A, Cen L, Eschrich S, Armaiz-Pena GN, Monteiro ANA. Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells. Scientific Reports. 11: 14334. PMID 34253763 DOI: 10.1038/s41598-021-93506-z |
0.303 |
|
| 2021 |
Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, et al. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. Jci Insight. 6. PMID 33793425 DOI: 10.1172/jci.insight.149895 |
0.302 |
|
| 2020 |
Colon-Echevarria CB, Ortiz T, Maldonado L, Hidalgo-Vargas MJ, Pérez-Morales J, Aquino-Acevedo AN, Herrera-Noriega R, Bonilla-Claudio M, Castro EM, Armaiz-Pena GN. Zoledronic Acid Abrogates Restraint Stress-Induced Macrophage Infiltration, PDGF-AA Expression, and Ovarian Cancer Growth. Cancers. 12. PMID 32962103 DOI: 10.3390/Cancers12092671 |
0.526 |
|
| 2020 |
Rodriguez-Rabassa M, Hernandez R, Rodriguez Z, Colon-Echevarria CB, Maldonado L, Tollinchi N, Torres-Marrero E, Mulero A, Albors D, Perez-Morales J, Flores I, Dutil J, Jim H, Castro EM, Armaiz-Pena GN. Impact of a natural disaster on access to care and biopsychosocial outcomes among Hispanic/Latino cancer survivors. Scientific Reports. 10: 10376. PMID 32587352 DOI: 10.1038/S41598-020-66628-Z |
0.408 |
|
| 2020 |
Rupaimoole R, Wu SY, Pradeep S, Ivan C, Pecot CV, Gharpure KM, Nagaraja AS, Armaiz-Pena GN, McGuire M, Zand B, Dalton HJ, Filant J, Miller JB, Lu C, Sadaoui NC, et al. Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nature Communications. 11: 2867. PMID 32493919 DOI: 10.1038/S41467-020-16661-3 |
0.387 |
|
| 2019 |
Colon-Echevarria CB, Lamboy-Caraballo R, Aquino-Acevedo AN, Armaiz-Pena GN. Neuroendocrine Regulation of Tumor-Associated Immune Cells. Frontiers in Oncology. 9: 1077. PMID 31737559 DOI: 10.3389/fonc.2019.01077 |
0.394 |
|
| 2019 |
Colon-Echevarria CB, Ortiz T, Maldonado-Laboy L, Hidalgo-Vargas MJ, Aquino AN, Armaiz-Pena GN. Abstract 512: Adrenergic modulation of inflammatory cytokines in ovarian cancer Immunology. DOI: 10.1158/1538-7445.Sabcs18-512 |
0.416 |
|
| 2019 |
Dash S, Gjyshi A, Cen L, Cheng C, Zhang C, Yoder SJ, Teer JK, Armaiz-Pena GN, Monteiro AN. Abstract 2669: A role forHOXA5in the transcriptional response of ovarian and fallopian tube surface epithelial cells to norepinephrine Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2669 |
0.301 |
|
| 2019 |
Colon-Echevarria CB, Ortiz T, Maldonado L, Hidalgo-Vargas MJ, Cruz-Rosa P, Maldonado A, Armaiz-Pena GN. Abstract # 3144 Adrenergic modulation of inflammatory cytokines in ovarian cancer Brain Behavior and Immunity. 76. DOI: 10.1016/J.Bbi.2018.11.263 |
0.532 |
|
| 2018 |
Shahzad MMK, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, et al. Stress effects on FosB and interleukin-8 ()-driven ovarian cancer growth and metastasis. The Journal of Biological Chemistry. 293: 10041. PMID 29959278 DOI: 10.1074/Jbc.Aac118.004299 |
0.584 |
|
| 2018 |
Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, et al. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. Jci Insight. 3. PMID 29889660 DOI: 10.1172/jci.insight.122389 |
0.302 |
|
| 2018 |
Gjyshi A, Dash S, Cen L, Cheng CH, Zhang C, Yoder SJ, Teer JK, Armaiz-Pena GN, Monteiro ANA. Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine. Scientific Reports. 8: 8291. PMID 29844388 DOI: 10.1038/s41598-018-26670-4 |
0.324 |
|
| 2018 |
Allen JK, Armaiz-Pena GN, Nagaraja AS, Sadaoui NC, Ortiz T, Dood R, Ozcan M, Herder DM, Haemerrle M, Gharpure KM, Rupaimoole R, Previs R, Wu SY, Pradeep S, Xu X, et al. Sustained adrenergic signaling promotes intratumoral innervation through BDNF induction. Cancer Research. PMID 29661830 DOI: 10.1158/0008-5472.Can-16-1701 |
0.538 |
|
| 2017 |
Sood AK, Dalton HJ, Pradeep S, McGuire M, Hailemichael Y, Ma S, Lyons Y, Armaiz-Pena GN, Previs RA, Hansen JM, Rupaimoole R, Gonzalez-Villasana V, Cho MS, Wu S, Mangala LS, et al. Macrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28855350 DOI: 10.1158/1078-0432.Ccr-17-0647 |
0.471 |
|
| 2017 |
Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, et al. Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens. Jci Insight. 2. PMID 28814667 DOI: 10.1172/Jci.Insight.93076 |
0.609 |
|
| 2017 |
Previs RA, Armaiz-Pena GN, Ivan C, Dalton HJ, Rupaimoole R, Hansen JM, Lyons Y, Huang J, Haemmerle M, Wagner MJ, Gharpure KM, Nagaraja AS, Filant J, McGuire MH, Noh K, et al. Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine Malignancies. Journal of the National Cancer Institute. 109. PMID 28376174 DOI: 10.1093/Jnci/Djw296 |
0.546 |
|
| 2017 |
Previs R, Moss T, Zand B, Hansen J, Dood R, Armaiz-Pena G, Lyons Y, Coleman R, Sood A. Pretty fly for GPI: Altered carbohydrate metabolism in ovarian cancer Gynecologic Oncology. 145: 13. DOI: 10.1016/J.Ygyno.2017.03.047 |
0.523 |
|
| 2016 |
Christensen DK, Armaiz-Pena GN, Ramirez E, Matsuo K, Zimmerman B, Zand B, Shinn E, Goodheart MJ, Bender D, Thaker PH, Ahmed A, Penedo FJ, DeGeest K, Mendez L, Domann F, et al. SSRI use and clinical outcomes in epithelial ovarian cancer. Oncotarget. PMID 27121207 DOI: 10.18632/Oncotarget.8891 |
0.561 |
|
| 2016 |
Haemmerle M, Bottsford-Miller J, Pradeep S, Taylor ML, Choi HJ, Hansen JM, Dalton HJ, Stone RL, Cho MS, Nick AM, Nagaraja AS, Gutschner T, Gharpure KM, Mangala LS, Rupaimoole R, ... ... Armaiz-Pena GN, et al. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. The Journal of Clinical Investigation. PMID 27064283 DOI: 10.1172/Jci85086 |
0.575 |
|
| 2016 |
Wu SY, Rupaimoole R, Shen F, Pradeep S, Pecot CV, Ivan C, Nagaraja AS, Gharpure KM, Pham E, Hatakeyama H, McGuire MH, Haemmerle M, Vidal-Anaya V, Olsen C, Rodriguez-Aguayo C, ... ... Armaiz-Pena GN, et al. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer. Nature Communications. 7: 11169. PMID 27041221 DOI: 10.1038/Ncomms11169 |
0.451 |
|
| 2016 |
Zand B, Previs RA, Zacharias NM, Rupaimoole R, Mitamura T, Nagaraja AS, Guindani M, Dalton HJ, Yang L, Baddour J, Achreja A, Hu W, Pecot CV, Ivan C, Wu SY, ... ... Armaiz-Pena G, et al. Role of Increased n-acetylaspartate Levels in Cancer. Journal of the National Cancer Institute. 108. PMID 26819345 DOI: 10.1093/Jnci/Djv426 |
0.533 |
|
| 2016 |
Rupaimoole R, Ivan C, Yang D, Gharpure KM, Wu SY, Pecot CV, Previs RA, Nagaraja AS, Armaiz-Pena GN, McGuire M, Pradeep S, Mangala LS, Rodriguez-Aguayo C, Huang L, Bar-Eli M, et al. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene. PMID 26725326 DOI: 10.1038/Onc.2015.492 |
0.507 |
|
| 2016 |
Previs RA, Armaiz-Pena GN, Ivan C, Dalton HJ, Huang J, Hansen JM, Hu W, Coleman RL, Sood AK. Two to tango: Biological activity and companion predictive markers for a novel dual AKT and P70S6K inhibitor in ovarian and uterine malignancies Gynecologic Oncology. 141: 5. DOI: 10.1016/J.Ygyno.2016.04.039 |
0.458 |
|
| 2015 |
Rupaimoole R, Lee J, Haemmerle M, Ling H, Previs RA, Pradeep S, Wu SY, Ivan C, Ferracin M, Dennison JB, Millward NM, Nagaraja AS, Gharpure KM, McGuire M, Sam N, ... Armaiz-Pena GN, et al. Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. Cell Reports. PMID 26686630 DOI: 10.1016/J.Celrep.2015.11.047 |
0.604 |
|
| 2015 |
Kang Y, Nagaraja AS, Armaiz-Pena GN, Dorniak PL, Hu W, Rupaimoole R, Liu T, Gharpure KM, Previs RA, Hansen JM, Rodriguez-Aguayo C, Ivan C, Ram PT, Sehgal V, Lopez-Berestein G, et al. Adrenergic stimulation of DUSP1 impairs chemotherapy response in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26581245 DOI: 10.1158/1078-0432.Ccr-15-1275 |
0.562 |
|
| 2015 |
Previs RA, Armaiz-Pena GN, Lin YG, Davis AN, Pradeep S, Dalton HJ, Hansen JM, Merritt WM, Nick AM, Langley RR, Coleman RL, Sood AK. Dual metronomic chemotherapy with nab-paclitaxel and topotecan has potent anti-angiogenic activity in ovarian cancer. Molecular Cancer Therapeutics. PMID 26516159 DOI: 10.1158/1535-7163.Mct-14-0630 |
0.578 |
|
| 2015 |
Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, et al. Erythropoietin Stimulates Tumor Growth via EphB4. Cancer Cell. PMID 26481148 DOI: 10.1016/J.Ccell.2015.09.008 |
0.609 |
|
| 2015 |
Nagaraja AS, Dorniak PL, Sadaoui NC, Kang Y, Lin T, Armaiz-Pena G, Wu SY, Rupaimoole R, Allen JK, Gharpure KM, Pradeep S, Zand B, Previs RA, Hansen JM, Ivan C, et al. Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis. Oncogene. PMID 26257064 DOI: 10.1038/Onc.2015.302 |
0.642 |
|
| 2015 |
Reyes-González JM, Armaiz-Peña GN, Mangala LS, Valiyeva F, Ivan C, Pradeep S, Echevarría-Vargas IM, Rivera-Reyes A, Sood AK, Vivas-Mejía PE. Targeting c-MYC in Platinum-Resistant Ovarian Cancer. Molecular Cancer Therapeutics. 14: 2260-9. PMID 26227489 DOI: 10.1158/1535-7163.Mct-14-0801 |
0.579 |
|
| 2015 |
Thanapprapasr D, Previs RA, Hu W, Ivan C, Armaiz-Pena GN, Dorniak PL, Hansen JM, Rupaimoole R, Huang J, Dalton HJ, Ali-Fehmi R, Coleman RL, Sood AK. PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer. Molecular Cancer Therapeutics. 14: 1466-75. PMID 25833835 DOI: 10.1158/1535-7163.Mct-14-1077 |
0.571 |
|
| 2015 |
Armaiz-Pena GN, Gonzalez-Villasana V, Nagaraja AS, Rodriguez-Aguayo C, Sadaoui NC, Stone RL, Matsuo K, Dalton HJ, Previs RA, Jennings NB, Dorniak P, Hansen JM, Arevalo JM, Cole SW, Lutgendorf SK, et al. Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth. Oncotarget. 6: 4266-73. PMID 25738355 DOI: 10.18632/Oncotarget.2887 |
0.575 |
|
| 2015 |
Nagaraja AS, Dorniak P, Sadaoui N, Armaiz-Pena G, Zand B, Wu SY, Allen JK, Rupaimoole R, Rodriguez-Aguayo C, Pradeep S, Tan L, Previs RA, Hansen JM, Yang P, Lopez-Berestein G, et al. Abstract 3368: Sustained adrenergic signaling activates pro-inflammatory prostaglandin network in ovarian carcinoma Cancer Research. 75: 3368-3368. DOI: 10.1158/1538-7445.Am2015-3368 |
0.577 |
|
| 2015 |
Armaiz-Pena GN, Gonzalez-Villasana V, Nagaraja AS, Rodriguez-Aguayo C, Dorniak P, Previs R, Sadaoui N, Stone R, Matsuo K, Dalton HJ, Lutgendorf SK, Sood AK, Lopez-Berestein G. Abstract 2359: Adrenergic regulation of MCP-1 leads to enhanced macrophage recruitment and ovarian carcinoma growth Cancer Research. 75: 2359-2359. DOI: 10.1158/1538-7445.Am2015-2359 |
0.596 |
|
| 2015 |
Previs RA, Moss TJ, Zand B, Rupaimoole R, Dalton HJ, Hansen JM, Armaiz-Pena G, Lutgendorf S, Coleman RL, Bhattacharya P, Ram P, Sood AK. Abstract 1199: Systems-based approach identifies altered carbohydrate metabolism as a predictor of a malignant phenotype in ovarian cancer Cancer Research. 75: 1199-1199. DOI: 10.1158/1538-7445.Am2015-1199 |
0.506 |
|
| 2015 |
Previs R, Moss T, Zand B, Rupaimoole R, Dalton H, Hansen J, Armaiz-Pena G, Lutgendorf S, Coleman R, Bhattacharya P, Ram P, Sood A. Fuel for the fire: Connecting genomics with metabolomics in ovarian cancer Gynecologic Oncology. 137: 67. DOI: 10.1016/J.Ygyno.2015.01.157 |
0.492 |
|
| 2015 |
Previs RA, Thanapprapasr D, Hu W, Rupaimoole R, Huang J, Dalton HJ, Ali R, Armaiz-Pena GN, Hansen JM, Zand B, Coleman RL, Sood AK. The FAK of uterine cancer: PTEN expression predicts response of uterine cancer to focal adhesion kinase inhibition Gynecologic Oncology. 137: 59. DOI: 10.1016/J.Ygyno.2015.01.136 |
0.546 |
|
| 2014 |
Rupaimoole R, Wu SY, Pradeep S, Ivan C, Pecot CV, Gharpure KM, Nagaraja AS, Armaiz-Pena GN, McGuire M, Zand B, Dalton HJ, Filant J, Miller JB, Lu C, Sadaoui NC, et al. Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nature Communications. 5: 5202. PMID 25351346 DOI: 10.1038/Ncomms6202 |
0.435 |
|
| 2014 |
Leung CS, Yeung TL, Yip KP, Pradeep S, Balasubramanian L, Liu J, Wong KK, Mangala LS, Armaiz-Pena GN, Lopez-Berestein G, Sood AK, Birrer MJ, Mok SC. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. Nature Communications. 5: 5092. PMID 25277212 DOI: 10.1038/Ncomms6092 |
0.606 |
|
| 2014 |
Gonzalez-Villasana V, Rodriguez-Aguayo C, Arumugam T, Cruz-Monserrate Z, Fuentes-Mattei E, Deng D, Hwang RF, Wang H, Ivan C, Garza RJ, Cohen E, Gao H, Armaiz-Pena GN, Del C Monroig-Bosque P, Philip B, et al. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Molecular Cancer Therapeutics. 13: 2583-94. PMID 25193509 DOI: 10.1158/1535-7163.Mct-14-0028 |
0.51 |
|
| 2014 |
Yang L, Moss T, Mangala LS, Marini J, Zhao H, Wahlig S, Armaiz-Pena G, Jiang D, Achreja A, Win J, Roopaimoole R, Rodriguez-Aguayo C, Mercado-Uribe I, Lopez-Berestein G, Liu J, et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Molecular Systems Biology. 10: 728. PMID 24799285 DOI: 10.1002/Msb.20134892 |
0.559 |
|
| 2014 |
Stone RL, Baggerly KA, Armaiz-Pena GN, Kang Y, Sanguino AM, Thanapprapasr D, Dalton HJ, Bottsford-Miller J, Zand B, Akbani R, Diao L, Nick AM, DeGeest K, Lopez-Berestein G, Coleman RL, et al. Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer. Cancer Biology & Therapy. 15: 919-29. PMID 24755674 DOI: 10.4161/Cbt.28882 |
0.571 |
|
| 2014 |
Gharpure KM, Chu KS, Bowerman CJ, Miyake T, Pradeep S, Mangala SL, Han HD, Rupaimoole R, Armaiz-Pena GN, Rahhal TB, Wu SY, Luft JC, Napier ME, Lopez-Berestein G, DeSimone JM, et al. Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer. Molecular Cancer Therapeutics. 13: 1750-7. PMID 24755199 DOI: 10.1158/1535-7163.Mct-13-0930 |
0.556 |
|
| 2014 |
Wu SY, Yang X, Gharpure KM, Hatakeyama H, Egli M, McGuire MH, Nagaraja AS, Miyake TM, Rupaimoole R, Pecot CV, Taylor M, Pradeep S, Sierant M, Rodriguez-Aguayo C, Choi HJ, ... ... Armaiz-Pena GN, et al. 2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity. Nature Communications. 5: 3459. PMID 24619206 DOI: 10.1038/Ncomms4459 |
0.494 |
|
| 2014 |
Dalton HJ, Armaiz-Pena GN, Gonzalez-Villasana V, Lopez-Berestein G, Bar-Eli M, Sood AK. Monocyte subpopulations in angiogenesis. Cancer Research. 74: 1287-93. PMID 24556724 DOI: 10.1158/0008-5472.Can-13-2825 |
0.543 |
|
| 2014 |
Sadaoui NC, Armaiz-Pena GN, Nagaraja AS, Rupaimoole R, Previs RA, Dalton HJ, Lingegowda MS, Ramondetta LM, Sood AK, Lutgendorf SK, Cole SW. Abstract 3511: Sustained adrenergic signaling promotes cervical cancer progression Cancer Research. 74: 3511-3511. DOI: 10.1158/1538-7445.Am2014-3511 |
0.574 |
|
| 2014 |
Previs RA, Ivan C, Dalton HJ, Davis AN, Bottsford-Miller JN, Zand B, McGuire MH, Armaiz-Pena GN, Coleman RL, Baggerly KA, Sood AK. Abstract 3340: Exploiting the non-overlapping dysregulation of Notch and PI3K/AKT signaling pathways as a guide for personalizing uterine cancer therapy Cancer Research. 74: 3340-3340. DOI: 10.1158/1538-7445.Am2014-3340 |
0.564 |
|
| 2014 |
Dalton HJ, Pradeep S, Armaiz-Pena GN, Previs R, Davis A, Rupaimoole R, Zand B, Hailemichael Y, Overwijk WW, Lopez-Berestein G, Sood AK. Abstract 2982: Macrophages modulate adaptive resistance to anti-angiogenic therapy Cancer Research. 74: 2982-2982. DOI: 10.1158/1538-7445.Am2014-2982 |
0.518 |
|
| 2014 |
Nagaraja AS, Armaiz-Pena G, Allen J, Sadaoui NC, Zand B, Yang P, Tan L, Cole S, Lutgendorf S, Sood AK. Abstract 158: Sustained adrenergic signaling activates pro-inflammatory networks in ovarian carcinoma Cancer Research. 74: 158-158. DOI: 10.1158/1538-7445.Am2014-158 |
0.574 |
|
| 2014 |
Armaiz-Pena GN, Nagaraja AS, Allen JK, Sadaoui NC, Rupaimoole R, wu sY, Pradeep S, Han HD, Zand B, Dalton H, Previs R, Taylor M, Bottsford-Miller J, Mangala LS, Rodriguez-Aguayo C, et al. Abstract 1062: Sustained adrenergic signaling promotes intratumoral innervation through BDNF induction Cancer Research. 74: 1062-1062. DOI: 10.1158/1538-7445.Am2014-1062 |
0.576 |
|
| 2013 |
Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, et al. Src activation by β-adrenoreceptors is a key switch for tumour metastasis. Nature Communications. 4: 1403. PMID 23360994 DOI: 10.1038/Ncomms2413 |
0.554 |
|
| 2013 |
Nagaraja AS, Armaiz-Pena GN, Lutgendorf SK, Sood AK. Why stress is BAD for cancer patients. The Journal of Clinical Investigation. 123: 558-60. PMID 23348736 DOI: 10.1172/Jci67887 |
0.565 |
|
| 2013 |
Armaiz-Pena GN, Cole SW, Lutgendorf SK, Sood AK. Neuroendocrine influences on cancer progression. Brain, Behavior, and Immunity. 30: S19-25. PMID 22728325 DOI: 10.1016/J.Bbi.2012.06.005 |
0.618 |
|
| 2013 |
Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, et al. Erratum: Corrigendum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis Nature Communications. 4. DOI: 10.1038/Ncomms2903 |
0.396 |
|
| 2012 |
Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, Deavers MT, Vasquez HG, Urbauer D, Landen CN, Hu W, et al. Paraneoplastic thrombocytosis in ovarian cancer. The New England Journal of Medicine. 366: 610-8. PMID 22335738 DOI: 10.1056/Nejmoa1110352 |
0.578 |
|
| 2011 |
Nick AM, Stone RL, Armaiz-Pena G, Ozpolat B, Tekedereli I, Graybill WS, Landen CN, Villares G, Vivas-Mejia P, Bottsford-Miller J, Kim HS, Lee JS, Kim SM, Baggerly KA, Ram PT, et al. Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death. Journal of the National Cancer Institute. 103: 1596-612. PMID 21957230 DOI: 10.1093/Jnci/Djr372 |
0.577 |
|
| 2011 |
Matsuo K, Nishimura M, Bottsford-Miller JN, Huang J, Komurov K, Armaiz-Pena GN, Shahzad MM, Stone RL, Roh JW, Sanguino AM, Lu C, Im DD, Rosenshien NB, Sakakibara A, Nagano T, et al. Targeting SRC in mucinous ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5367-78. PMID 21737505 DOI: 10.1158/1078-0432.Ccr-10-3176 |
0.581 |
|
| 2011 |
Kim HS, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MM, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, et al. Functional roles of Src and Fgr in ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1713-21. PMID 21300758 DOI: 10.1158/1078-0432.Ccr-10-2081 |
0.602 |
|
| 2011 |
Nick AM, Stone RL, Chang B, Liu J, Urbauer D, Mora E, Pecot C, Mangala L, Han H, Vivas-Mejias P, Sung B, Nishimura M, Matsuo K, Kannan S, Zweidler-McKay P, ... ... Armaiz-Pena GN, et al. Abstract 4457: In Search of a novel EPO receptor: The clinical significance of the Eph connection Cancer Research. 71: 4457-4457. DOI: 10.1158/1538-7445.Am2011-4457 |
0.367 |
|
| 2011 |
Mora EM, Pecot CV, Nick AM, Mangala LS, Han HD, Stein MA, Brock S, Vivas-Mejias P, Sung B, Nishimura M, Matsuo K, Kannan S, Zweidler-McKay PA, Armaiz-Pena GN, Shahzad MMK, et al. Abstract 1618: Erythropoietin meets a new receptor Cancer Research. 71: 1618-1618. DOI: 10.1158/1538-7445.Am2011-1618 |
0.577 |
|
| 2011 |
Shahzad M, Arevalo J, Stone R, Armaiz-Pena G, Bottsford-Miller J, Nick A, Lutgendorf S, Lopez-Berestein G, Cole S, Sood A. Stress and the metastatic switch in epithelial ovarian carcinoma Gynecologic Oncology. 120: S55. DOI: 10.1016/J.Ygyno.2010.12.133 |
0.459 |
|
| 2011 |
Nick A, Stone R, Bottsford-Miller J, Ramirez P, Tung C, Armaiz-Pena G, Felix E, Sood A. Stop and smell the volatile organic compounds: A novel breath-based bioassay for detection of ovarian cancer Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.132 |
0.475 |
|
| 2011 |
Allen JK, Armaiz-Pena GN, Jennings NB, Sood AK, Lutgendorf SK, Cole SW. 208. BDNF is involved in mediating stress-effects on ovarian cancer progression Brain Behavior and Immunity. 25. DOI: 10.1016/J.Bbi.2011.07.211 |
0.558 |
|
| 2011 |
Armaiz-Pena GN, Stone RL, Nick AM, Allen JK, Deavers MT, Jackson D, Wiktorowicz JE, Cruz A, Vivas-Mejias P, Lopez-Berestein G, Cole SW, Lutgendorf SK, Sood AK. 89. Src activation by beta adrenoreceptors is a key switch for microenvironmental regulation of tumor metastasis Brain Behavior and Immunity. 25. DOI: 10.1016/J.Bbi.2011.07.092 |
0.475 |
|
| 2010 |
Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, et al. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. The Journal of Biological Chemistry. 285: 35462-70. PMID 20826776 DOI: 10.1074/Jbc.M110.109579 |
0.524 |
|
| 2010 |
Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell. 18: 185-97. PMID 20708159 DOI: 10.1016/J.Ccr.2010.06.016 |
0.58 |
|
| 2010 |
Sood AK, Armaiz-Pena GN, Halder J, Nick AM, Stone RL, Hu W, Carroll AR, Spannuth WA, Deavers MT, Allen JK, Han LY, Kamat AA, Shahzad MM, McIntyre BW, Diaz-Montero CM, et al. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. The Journal of Clinical Investigation. 120: 1515-23. PMID 20389021 DOI: 10.1172/Jci40802 |
0.626 |
|
| 2010 |
Lu C, Shahzad MM, Moreno-Smith M, Lin YG, Jennings NB, Allen JK, Landen CN, Mangala LS, Armaiz-Pena GN, Schmandt R, Nick AM, Stone RL, Jaffe RB, Coleman RL, Sood AK. Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biology & Therapy. 9: 176-82. PMID 20009575 DOI: 10.4161/Cbt.9.3.10635 |
0.524 |
|
| 2010 |
Stone RL, Nick AM, Afshar-Kharghan V, Vasquez HG, Landen CN, Armaiz-Pena G, Carroll AR, Matsuo K, Shahzad MMK, Spannuth WA, Mora EM, King ER, DeGeest K, Lutgendorf S, Sood AK. Abstract 3436: Mechanisms of paraneoplastic thrombocytosis in ovarian carcinoma Cancer Research. 70: 3436-3436. DOI: 10.1158/1538-7445.Am10-3436 |
0.55 |
|
| 2010 |
Carroll A, Kim SW, Nick AM, Stone RL, Spannuth WA, Armaiz-Pena GN, Matsuo K, Vivas-Mejia PE, Mangala S, Mora EM, Shahzad M, Lopez-Berestein G, Sood AK. Abstract 1811: Breaking scaffolds: Targeting paxillin in ovarian cancer Cancer Research. 70: 1811-1811. DOI: 10.1158/1538-7445.Am10-1811 |
0.656 |
|
| 2010 |
Armaiz-Pena GN, Halder J, Nick AM, Stone RL, Spannuth WA, Deavers MT, Allen JK, Han LY, Kamat AA, Shahzad MMK, McIntyre BW, Diaz-Montero CM, Jennings NB, Lin YG, Merritt WM, et al. Abstract 1725: Neuroendocrine modulation of anoikis Cancer Research. 70: 1725-1725. DOI: 10.1158/1538-7445.Am10-1725 |
0.614 |
|
| 2010 |
Nick AM, Stone RL, Spannuth WA, Landen CN, Villares G, Armaiz-Pena G, Carroll AR, Ozpolat B, Tekedereli I, Vivas-Mejia P, Coleman RL, Lopez-Berestein G, Sood AK. Abstract 1044: Silencing p130cas in ovarian carcinoma induces autophagic cell death Cancer Research. 70: 1044-1044. DOI: 10.1158/1538-7445.Am10-1044 |
0.613 |
|
| 2009 |
Kim TJ, Landen CN, Lin YG, Mangala LS, Lu C, Nick AM, Stone RL, Merritt WM, Armaiz-Pena G, Jennings NB, Coleman RL, Tice DA, Sood AK. Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer. Cancer Biology & Therapy. 8: 2263-72. PMID 19829059 DOI: 10.4161/Cbt.8.23.10134 |
0.535 |
|
| 2009 |
Mangala LS, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MM, Lin YG, Nick AM, Danes CG, Lee JW, Jennings NB, Vivas-Mejia PE, et al. Therapeutic Targeting of ATP7B in Ovarian Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3770-80. PMID 19470734 DOI: 10.1158/1078-0432.Ccr-08-2306 |
0.47 |
|
| 2009 |
Armaiz-Pena GN, Mangala LS, Spannuth WA, Lin YG, Jennings NB, Nick AM, Langley RR, Schmandt R, Lutgendorf SK, Cole SW, Sood AK. Estrous cycle modulates ovarian carcinoma growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2971-8. PMID 19383821 DOI: 10.1158/1078-0432.Ccr-08-2525 |
0.621 |
|
| 2009 |
Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2695-702. PMID 19351748 DOI: 10.1158/1078-0432.Ccr-08-2966 |
0.549 |
|
| 2009 |
Spannuth WA, Nick AM, Jennings NB, Armaiz-Pena GN, Mangala LS, Danes CG, Lin YG, Merritt WM, Thaker PH, Kamat AA, Han LY, Tonra JR, Coleman RL, Ellis LM, Sood AK. Functional significance of VEGFR-2 on ovarian cancer cells. International Journal of Cancer. Journal International Du Cancer. 124: 1045-53. PMID 19058181 DOI: 10.1002/Ijc.24028 |
0.615 |
|
| 2009 |
Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK. Neuroendocrine modulation of cancer progression. Brain, Behavior, and Immunity. 23: 10-5. PMID 18638541 DOI: 10.1016/J.Bbi.2008.06.007 |
0.536 |
|
| 2009 |
Sood AK, Lin YG, Armaiz-Pena G, Lutgendorf SK, Aggarwal BB. 116. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway Brain Behavior and Immunity. 23. DOI: 10.1016/J.Bbi.2009.06.121 |
0.55 |
|
| 2009 |
Armaiz-Pena G, Villares G, Han L, Lin Y, Sanguino A, Deavers M, Gallick G, Bar-Eli M, Lopez-Berestein G, Cole S, Lutgendorf S, Sood A. 5. Molecular mechanisms of Src activation in chronic stress-induced cancer growth Brain, Behavior, and Immunity. 23: S26. DOI: 10.1016/J.Bbi.2009.06.010 |
0.531 |
|
| 2008 |
Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, Shahzad MM, Tsang YT, Armaiz-Pena GN, Lu C, Kamat AA, Han LY, Spannuth WA, Nick AM, Landen CN, Wong KK, et al. Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5437-46. PMID 18765535 DOI: 10.1158/1078-0432.Ccr-07-4922 |
0.6 |
|
| 2008 |
Armaiz-Pena GN, Mangala LS, Han LY, Lin YG, Schmandt R, Sanguino AM, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. 34. Chronic stress promotes tumor growth through a Src-dependent mechanism in a mouse model of ovarian cancer Brain Behavior and Immunity. 22: 9-10. DOI: 10.1016/J.Bbi.2008.04.035 |
0.606 |
|
| 2008 |
Schmandt R, Sood AK, Lutgendorf SK, Mangala LS, Armaiz-Pena G. 29. Exercise therapy for ovarian cancer: How does exercise counteract stress-induced tumor growth? Brain Behavior and Immunity. 22: 8. DOI: 10.1016/J.Bbi.2008.04.030 |
0.515 |
|
| 2007 |
Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism Journal of Biological Chemistry. 282: 29919-29926. PMID 17716980 DOI: 10.1074/Jbc.M611539200 |
0.564 |
|
| 2007 |
Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, Sood AK. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3423-30. PMID 17545551 DOI: 10.1158/1078-0432.Ccr-06-3072 |
0.578 |
|
| 2006 |
Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma Nature Medicine. 12: 939-944. PMID 16862152 DOI: 10.1038/Nm1447 |
0.609 |
|
| 2006 |
Sood AK, Thaker PH, Jennings N, Kamat AA, Han LY, Armaiz-Pena G, Lopez-Berestein G, Lutgendorf SK, Cole SW. Tumor cell β adrenergic receptor dependence for chronic stress effects on ovarian cancer growth Brain Behavior and Immunity. 20: 66-67. DOI: 10.1016/J.Bbi.2006.04.149 |
0.587 |
|
| Show low-probability matches. |